R&D Scientific Advisors
Impax Pharmaceuticals Scientific Advisory Board
Impax Pharmaceuticals actively collaborates with global leaders in neurology specialized in Parkinson’s disease and other movement disorders. Advisory members routinely provide valuable input to pharmaceutical development efforts of existing and potential new pipeline programs.
Stanley Fahn, M.D.
Columbia University
Dr. Fahn is Movement Disorders Division Chief and H. Houston Merritt Professor of Neurology.
Christopher Goetz, M.D.
Rush University
Dr. Goetz is Director of the movement disorders program of Rush University Medical Center.
Robert A. Hauser, M.D.
MBA, University of South Florida
Dr. Hauser is Professor of Neurology, Molecular Pharmacology, and Physiology and Director of the Parkinson's Disease & Movement Disorders Center.
Karl Kieburtz, M.D., M.P.H.
University of Rochester
Dr. Kieburtz is Director, Center for Human Experimental Therapeutics and Professor, Department of Neurology, Professor, Department of Environmental Medicine and Professor, Department of Community & Preventive Medicine.
Rajesh Pahwa, M.D.
University of Kansas
Dr. Pahwa is Professor of Neurology at the University of Kansas Medical Center.
Werner Poewe, M.D.
Medical University of Innsbruck, Austria
Professor Poewe is Chairman of the Department of Neurology.
Olivier Rascol, M.D.
Ph.D., University Hospital, Toulouse, France
Dr. Rascol is Professor of Clinical Pharmacology and medical neurologist and has a Ph.D. in Neurosciences.
